Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Buy

Debt to Equity Rating

Buy

Price to Earnings Rating

Buy

Analyst Rating

Buy

Simple Moving Average

Sell

Exponential Moving Average

Sell

Relative Strength Index

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Eagle Pharmaceuticals, Inc. (EGRX)

Pharmaceutical Preparations

http://www.eagleus.com

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.

50 TICE BOULEVARD, SUITE 315
WOODCLIFF LAKE, NJ

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/12/2014

Market Cap

57,727,215

Shares Outstanding

12,990,000

Weighted SO

12,986,971

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

ANIP --.--%

PAHC --.--%

DCPH --.--%

PBH --.--%

COLL --.--%

SSIC --.--%

RGC --.--%

AMPH --.--%

ALKS --.--%

Beta

0.5120

Last Div

0.0000

Range

3.21-18.33

Chg

0.4650

Avg Vol

173196

Mkt Cap

57727215

Exch

NASDAQ

Country

US

Phone

201 326 5300

DCF Diff

10.0978

DCF

43.8478

Div Yield

0.0000

P/S

0.4408

EV Multiple

5.0045

P/FV

0.2309

Div Yield %

0.0000

P/E

5.3316

PEG

0.0103

Payout

0.0000

Current Ratio

2.1615

Quick Ratio

1.6711

Cash Ratio

0.1772

DSO

320.9300

DIO

453.9472

Op Cycle

774.8772

DPO

169.2926

CCC

605.5847

Gross Margin

0.7392

Op Margin

0.1259

Pretax Margin

0.1491

Net Margin

0.0833

Eff Tax Rate

0.4411

ROA

0.0270

ROE

0.0441

ROCE

0.0518

NI/EBT

0.5589

EBT/EBIT

1.1842

EBIT/Rev

0.1259

Debt Ratio

0.1734

D/E

0.2785

LT Debt/Cap

0.1972

Total Debt/Cap

0.2178

Int Coverage

5.5638

CF/Debt

-0.4792

Equity Multi

1.6062

Rec Turnover

1.1373

Pay Turnover

2.1560

Inv Turnover

0.8041

FA Turnover

129.2705

Asset Turnover

0.3235

OCF/Share

-2.5696

FCF/Share

-2.5745

Cash/Share

1.1729

OCF/Sales

-0.2569

FCF/OCF

1.0019

CF Coverage

-0.4792

ST Coverage

-4.0542

CapEx Coverage

-525.5938

Div&CapEx Cov

-525.5938

P/BV

0.2309

P/B

0.2309

P/S

0.4408

P/E

5.3316

P/FCF

-1.7129

P/OCF

-1.7299

P/CF

-1.7299

PEG

0.0103

P/S

0.4408

EV Multiple

5.0045

P/FV

0.2309

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Oct 14, 22:13 Snowflake, Eagle Pharmaceuticals, Blue Ridge Bankshares, and Amplitude Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information GlobeNewswire Inc. Jan 18, 06:50 Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio GlobeNewswire Inc. Nov 29, 07:35 Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q GlobeNewswire Inc. Nov 29, 07:30 Eagle Pharmaceuticals Announces Management Change GlobeNewswire Inc. Nov 09, 07:30 Eagle Delays Third Quarter 2023 Results and Conference Call

Revenue Product Segmentation